Healthcare Press

Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking At

  • 📰 Forbes
  • ⏱ Reading Time:
  • 13 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 40%
  • Publisher: 53%

Ozempic News

Glp-1,Mounjaro,Weight Loss

I am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.

Weight loss and diabetes may just be the beginning for drugs like Ozempic, Wegovy, Mounjaro and Zepbound as reports increasingly suggest they may have far-reaching benefits for treating conditions as diverse as heart and liver disease, Parkinson’s, anxiety and addiction, sparking researchNovo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound — brand names for drugs semaglutide and tirzepatide — are far and away the most famous members of a booming class of medications known as...

The sheer number of people who take a medication after approval, especially popular ones like semaglutide and tirzepatide, can dwarf the number of people involved in a trial and companies and regulators alike monitor how they fare in the real world.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ozempic Babies: Weight Loss Drugs, Pregnancy Risks, Fertility BenefitsA. Pawlowski is a TODAY health reporter focusing on health news and features. Previously, she was a writer, producer and editor at CNN.
Source: TODAYshow - 🏆 389. / 55 Read more »